Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou New Century Institute of Vitiligo appears to be a China-based specialty dermatology clinic and research institute focused on the diagnosis and treatment of vitiligo. Publicly available descriptions consistently present it as a dedicated vitiligo hospital or prevention and treatment research institute in Guangzhou, Guangdong. The organization appears to provide clinical care rather than develop a broad proprietary drug pipeline, with available evidence centered on vitiligo management and surgical repigmentation procedures. A 2025 peer-reviewed case series affiliated with the institute reported use of autologous serum plus non-cultured epidermal cell suspension transplantation for stable vitiligo, suggesting active participation in clinical research alongside patient treatment. Overall, the entity is best characterized as a specialized healthcare provider and research-oriented clinic in dermatology rather than a traditional biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou New Century Institute of Vitiligo.